Investor DD - another change to the Investor presentation Feb 2014 Timeline
Another even bigger change is on page 13. In the past Insmed had said they would be finished discussions with the FDA and EU regarding their path to approval BY THE END OF the first quarter NOW- .The change is : Q2: Continued dialogue with EMA and FDA regarding NTM regulatory path
● Q2: ● Exact timing dependent on NTM data and EMA regulatory dialogue
betcha I nailed it months ago ...bash away kids, but investors take note.
Watch the market for a turn, the trading looks like a headfake - last one . Good Luck
Terry. Go back and read the November 2013 Investor presentation on page 24. Under 2014's heading of 1st Half, it states: "NTM Data and FDA dialogue". I don't know how book smart you are, but dialogue and discussion seem to have the same meaning. Insmed stated it would be in the first 6 months of 2014, which is January to June for the FDA dialogue and/or discussion, not "BY THE END of the first quarter NOW"
The only things you nailed are the presentation of false facts again and the manifestation of your agenda.